ストックスクリーナーアプリを入手
13.69
0.96%
0.13
CorMedix Inc (CRMD) 最新ニュース
Is Now a Good Time to Reenter CorMedix Inc.July 2025 Sector Moves & Verified Momentum Stock Watchlist - newsyoung.net
NJ Judge Files Corrected Version Of Error-Filled Opinion - Law360
Will CorMedix Inc. Bounce From 52 Week Low2025 Major Catalysts & Trade Opportunity Analysis - mustnews.co.kr
CorMedix (CRMD) Soars 5.1%: Is Further Upside Left in the Stock? - MSN
CorMedix Doubles Down On Infection Prevention With DefenCath Success - Finimize
Wall Street Analysts Believe CorMedix (CRMD) Could Rally 45.63%: Here's is How to Trade - Yahoo Finance
CorMedix’s DEFENCATH® Study: A Potential Game-Changer in Infection Prevention - MSN
Will CorMedix Inc. benefit from AI trendsJuly 2025 Update & Stock Market Timing Techniques - mustnews.co.kr
Why CorMedix Inc. stock attracts strong analyst attentionWeekly Risk Report & Capital Efficiency Focused Ideas - thegnnews.com
Needham Maintains a Buy Rating on CorMedix (CRMD) With a $20 PT - MSN
Cormedix Receives Buy Rating from RBC Capital, Analyst Sees 45% Upside Potential - AInvest
CorMedix (CRMD) Surpasses Q2 Earnings and Revenue Estimates - MSN
CorMedix Inc. Advances in Infection Prevention with DEFENCATH® Study - TipRanks
Why CorMedix (CRMD) Might be Well Poised for a Surge - sharewise.com
Cormedix Inc. Advances Pediatric Study on DefenCath® for Infection Prevention - TipRanks
CorMedix's (NASDAQ:CRMD) Earnings Aren't As Good As They Appear - Yahoo Finance
Statutory Earnings May Not Be The Best Way To Understand CorMedix's (NASDAQ:CRMD) True Position - simplywall.st
CorMedix (CRMD.O) Surges 8% — Is It a Technical Trigger or a Broader Sector Play? - AInvest
CorMedix Raises $150M in Convertible Notes Offering - AInvest
Undervalued Healthcare Stocks to Buy: Eli Lilly, CorMedix, and Johnson & Johnson - AInvest
Time to Buy Eli Lilly and Other Undervalued Healthcare Stocks? - ca.finance.yahoo.com
Momentum Screeners Rank CorMedix Inc. in Top 5 TodayAI Screening for Swing Trade Picks Finds Momentum - sundaytimes.kr
CorMedix Inc. Just Beat EPS By 50%: Here's What Analysts Think Will Happen Next - 富途牛牛
CorMedix Completes $150M Convertible Notes Offering - TipRanks
CorMedix completes $150 million convertible notes offering on Nasdaq By Investing.com - Investing.com Nigeria
CorMedix completes $150 million convertible notes offering on Nasdaq - Investing.com
Unpacking CorMedix’s 14.2% Intraday Surge: What’s Driving the Move? - AInvest
CorMedix (CRMD.O) Surges 9.7% Intraday—No Fundamentals, So What's Driving It? - AInvest
CorMedix’s SWOT analysis: acquisition boosts biopharmaceutical stock’s outlook By Investing.com - Investing.com Nigeria
CorMedix’s SWOT analysis: acquisition boosts biopharmaceutical stock’s outlook - Investing.com
Xenon Q2 Loss Wider Than Expected, Pipeline Development in Focus - Zacks Investment Research
CorMedix Inc. (NASDAQ:CRMD) Q2 2025 Earnings Call Transcript - Insider Monkey
CorMedix Inc. Earnings Call Highlights Strategic Growth - TipRanks
Both Individual Investors Who Control a Good Portion of CorMedix Inc. (NASDAQ:CRMD) Along With Institutions Must Be Dismayed After Last Week's 16% Decrease - 富途牛牛
CorMedix Inc. stock trend outlook and recovery pathShort Squeeze Opportunities with Indicators - Newser
Is CorMedix Inc. part of any ETFShort-Term Gainers List - thegnnews.com
CorMedix Inc. stock trend forecastFree Real-Time Analysis With Entry Targets - Newser
Short Interest Drops in CorMedix Inc. After RallyReal-Time Analysis With Entry Targets In Progress - beatles.ru
Strategic Value and Growth Potential of CorMedix Post-Melinta Acquisition - AInvest
CorMedix Strikes $300M Deal For Melinta Therapeutics, Retail Calls It A ‘Wonderful Acquisition’ - Stocktwits
CorMedix Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
How did CRMD's Q4 earnings surprise impact investor confidence? - AInvest
It's A Story Of Risk Vs Reward With CorMedix Inc. (NASDAQ:CRMD) - simplywall.st
Cormedix Inc Reports Q2 2025 Earnings: $39.7M in Revenue, $0.29 EPS, and Acquisition of Melinta Therapeutics - AInvest
Applying big data sentiment scoring on CorMedix Inc.Free Consistent Income Focused Trade List - Newser
Press Release: Cormedix Inc. Reports Second Quarter 2025 Financial Results and Provides Business Update - 富途牛牛
0.94%
1.72%
大文字化:
|
ボリューム (24 時間):